Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat Latent Mycobacterium tuberculosis Infection

about

Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat Latent Mycobacterium tuberculosis Infection

Item

http://www.wikidata.org/entity/Q56067172

description

im Juni 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в червні 2018

@uk

name

Update of Recommendations for ...... cterium tuberculosis Infection

@en

Update of Recommendations for ...... cterium tuberculosis Infection

@nl

type

Item

label

Update of Recommendations for ...... cterium tuberculosis Infection

@en

Update of Recommendations for ...... cterium tuberculosis Infection

@nl

prefLabel

Update of Recommendations for ...... cterium tuberculosis Infection

@en

Update of Recommendations for ...... cterium tuberculosis Infection

@nl

P1476

Update of Recommendations for ...... cterium tuberculosis Infection

@en

P2093

Andrew Vernon

http://www.w3.org/2001/XMLSchema#string

Andrey S Borisov

http://www.w3.org/2001/XMLSchema#string

Carla A Winston

http://www.w3.org/2001/XMLSchema#string

Deron Burton

http://www.w3.org/2001/XMLSchema#string

Gibril J Njie

http://www.w3.org/2001/XMLSchema#string

Leeanna Allen

http://www.w3.org/2001/XMLSchema#string

Philip LoBue

http://www.w3.org/2001/XMLSchema#string

Rachel Yelk Woodruff

http://www.w3.org/2001/XMLSchema#string

Sapna Bamrah Morris

http://www.w3.org/2001/XMLSchema#string

Stefan Goldberg

http://www.w3.org/2001/XMLSchema#string

P2860

Data collection instrument and procedure for systematic reviews in the Guide to Community Preventive Services. Task Force on Community Preventive Services.

Flu-like and Other Systemic Drug Reactions Among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVENT Tuberculosis Study.

Pharmacokinetic interaction of rifapentine and raltegravir in healthy volunteers.

Developing an evidence-based Guide to Community Preventive Services--methods. The Task Force on Community Preventive Services.

Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention

Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons

Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid.

Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection: A Randomized Trial.

Isoniazid-Rifapentine for Latent Tuberculosis Infection: A Systematic Review and Meta-analysis

P304

723-726

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.15585/MMWR.MM6725A5

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-06-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29953429

http://www.w3.org/2001/XMLSchema#string

P921

Mycobacterium tuberculosis

P932

6023184

http://www.w3.org/2001/XMLSchema#string